{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:29:21Z","timestamp":1793147361081,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013394","name":"REGENXBIO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtm.2020.05.015","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T21:49:23Z","timestamp":1590097763000},"page":"50-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model"],"prefix":"10.1016","volume":"18","author":[{"given":"Kazuki","family":"Sawamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha","family":"Karumuthil-Melethil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaukat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Danos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.05.015_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9610(29)90496-7","article-title":"Chondro-osteo-dystrophy, roentgenopgraphic & clinical features of a child with dislocation of vertebrae","volume":"7","author":"Brailsford","year":"1929","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.omtm.2020.05.015_bib2","first-page":"129","article-title":"Sur une forme de dystrophie osseuse familial","volume":"32","author":"Morquio","year":"1929","journal-title":"Arch. M\u00e9d. Enfants Paris."},{"key":"10.1016\/j.omtm.2020.05.015_bib3","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.omtm.2020.05.015_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2016.11.007","article-title":"Mucopolysaccharidosis IVA and glycosaminoglycans","volume":"120","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2018.05.004","article-title":"Molecular genetics and metabolism, special edition: diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA","volume":"125","author":"Peracha","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib6","series-title":"Mucopolysaccharidoses Update","first-page":"235","article-title":"Mucopolysaccharidosis type IVA: clinical features, biochemistry, diagnosis, genetics, and treatment","author":"Sawamoto","year":"2018"},{"key":"10.1016\/j.omtm.2020.05.015_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ymgme.2015.09.007","article-title":"Obstructive airway in Morquio A syndrome, the past, the present and the future","volume":"117","author":"Tomatsu","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2018.03.004","article-title":"Growth impairment in mucopolysaccharidoses","volume":"124","author":"Melbouci","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.05.015_bib10","first-page":"65","article-title":"Current and emerging treatments and surgical interventions for Morquio A syndrome: a review","volume":"2012","author":"Tomatsu","year":"2012","journal-title":"Res. Rep. Endocr. Disord."},{"key":"10.1016\/j.omtm.2020.05.015_bib11","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.athoracsur.2016.02.113","article-title":"Surgical reconstruction for severe tracheal obstruction in Morquio A syndrome","volume":"102","author":"Pizarro","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.omtm.2020.05.015_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","article-title":"Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations","volume":"3","author":"Tomatsu","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.omtm.2020.05.015_bib14","first-page":"42","article-title":"30 Months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: about one case","volume":"9","author":"Do Cao","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2020.05.015_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s10038-019-0604-6","article-title":"Effect of enzyme replacement therapy on the growth of patients with Morquio A","volume":"64","author":"Doherty","year":"2019","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtm.2020.05.015_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2016.04.005","article-title":"Activity of daily living for Morquio A syndrome","volume":"118","author":"Yasuda","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","article-title":"Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis","volume":"125","author":"Khan","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib18","first-page":"100455","article-title":"Biomarkers in patients with mucopolysaccharidosis type II and IV","volume":"19","author":"Fujitsuka","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2020.05.015_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.05.015_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40262-014-0173-y","article-title":"Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome","volume":"53","author":"Qi","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.omtm.2020.05.015_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/21678707.2016.1214572","article-title":"Current therapies for Morquio A syndrome and their clinical outcomes","volume":"4","author":"Sawamoto","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.omtm.2020.05.015_bib22","first-page":"31","article-title":"Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA","volume":"1","author":"Chinen","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2020.05.015_bib23","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/DDDT.S68562","article-title":"Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome","volume":"9","author":"Tomatsu","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","article-title":"Hematopoietic stem cell transplantation for Morquio A syndrome","volume":"117","author":"Yabe","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib25","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.bbmt.2016.08.015","article-title":"Allogeneic hematopoietic stem cell transplantation in thirty-four pediatric cases of mucopolysaccharidosis\u2014a ten-year report from the China Children Transplant Group","volume":"22","author":"Wang","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2020.05.015_bib26","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2020.05.015_bib27","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","article-title":"Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns\u2212\/\u2212) produced by targeted disruption of the gene defective in Morquio A disease","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.05.015_bib28","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","article-title":"Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase","volume":"14","author":"Tomatsu","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.05.015_bib29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/mt.2010.32","article-title":"Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome","volume":"18","author":"Tomatsu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2014.05.013","article-title":"Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib31","series-title":"Enzyme Replacement Therapy. Lysosomal Disorders of the Brain","first-page":"327","author":"Neufeld","year":"2004"},{"key":"10.1016\/j.omtm.2020.05.015_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.omtm.2020.05.015_bib33","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1089\/104303401753204571","article-title":"Various cells retrovirally transduced with N-acetylgalactosoamine-6-sulfate sulfatase correct Morquio skin fibroblasts in\u00a0vitro","volume":"12","author":"Toietta","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib34","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s11033-008-9392-3","article-title":"Effect of elongation factor 1\u03b1 promoter and SUMF1 over in\u00a0vitro expression of N-acetylgalactosamine-6-sulfate sulfatase","volume":"36","author":"Alm\u00e9ciga-D\u00edaz","year":"2009","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omtm.2020.05.015_bib35","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1111\/j.1742-4658.2010.07769.x","article-title":"Adeno-associated virus gene transfer in Morquio A disease\u2014effect of promoters and sulfatase-modifying factor 1","volume":"277","author":"Alm\u00e9ciga-D\u00edaz","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.omtm.2020.05.015_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41390-018-0095-8","article-title":"Tailoring the AAV2 capsid vector for bone-targeting","volume":"84","author":"Alm\u00e9ciga-D\u00edaz","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.omtm.2020.05.015_bib37","series-title":"FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss","year":"2017"},{"key":"10.1016\/j.omtm.2020.05.015_bib38","series-title":"FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality","year":"2019"},{"key":"10.1016\/j.omtm.2020.05.015_bib39","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/mt.2011.107","article-title":"Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques","volume":"19","author":"Mattar","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/humc.2017.014","article-title":"Non-clinical study examining AAV8.TBG.hLDLR vector-associated toxicity in chow-fed wild-type and LDLR+\/\u2212 rhesus macaques","volume":"28","author":"Greig","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2020.05.015_bib41","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.ymthe.2017.04.003","article-title":"In utero transfer of adeno-associated viral vectors produces long-term factor IX levels in a cynomolgus macaque model","volume":"25","author":"Mattar","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mthe.2000.0031","article-title":"Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver","volume":"1","author":"Wang","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib43","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in\u00a0vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.05.015_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","article-title":"AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of \u03b1-galactosidase A and the induction of immune tolerance in Fabry mice","volume":"9","author":"Ziegler","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib45","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.gt.3302549","article-title":"AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL","volume":"12","author":"Sondhi","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib46","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.0508685103","article-title":"Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T\u00a0cells","volume":"103","author":"Dobrzynski","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.05.015_bib47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood-2007-02-073304","article-title":"Induction and role of regulatory CD4+CD25+ T\u00a0cells in tolerance to the transgene product following hepatic in\u00a0vivo gene transfer","volume":"110","author":"Cao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.05.015_bib48","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","article-title":"Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver","volume":"110","author":"Mingozzi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.05.015_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.mt.6300325","article-title":"Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle","volume":"16","author":"Tessitore","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/mt.2010.257","article-title":"Long-term amelioration of feline mucopolysaccharidosis VI after AAV-mediated liver gene transfer","volume":"19","author":"Cotugno","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.015_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","article-title":"Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide","volume":"88","author":"Nishioka","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2008.01.007","article-title":"Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice","volume":"94","author":"Monta\u00f1o","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib53","doi-asserted-by":"crossref","first-page":"19430","DOI":"10.1016\/S0021-9258(19)77651-0","article-title":"The primary structure of a cell-binding bone sialoprotein","volume":"263","author":"Oldberg","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.05.015_bib54","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1359\/jbmr.2000.15.5.936","article-title":"Selective drug delivery system to bone: small peptide (Asp)6 conjugation","volume":"15","author":"Kasugai","year":"2000","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.05.015_bib55","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/01.PDR.0000113767.60140.E9","article-title":"Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA","volume":"55","author":"Tomatsu","year":"2004","journal-title":"Pediatr. Res."},{"issue":"Suppl 3","key":"10.1016\/j.omtm.2020.05.015_bib56","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/s10545-009-9013-x","article-title":"Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.05.015_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/BMI.S7451","article-title":"Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine","volume":"6","author":"Hintze","year":"2011","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.omtm.2020.05.015_bib58","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4155\/bio.11.172","article-title":"Validation of an LC-MS\/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome","volume":"3","author":"Martell","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.omtm.2020.05.015_bib59","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.05.015_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2016.05.018","article-title":"Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome","volume":"119","author":"Hendriksz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.015_bib61","first-page":"59","article-title":"Mortality in patients with Morquio syndrome A","volume":"15","author":"Lavery","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.omtm.2020.05.015_bib62","doi-asserted-by":"crossref","first-page":"e0162612","DOI":"10.1371\/journal.pone.0162612","article-title":"Heart and cardiovascular involvement in patients with mucopolysaccharidosis type IVA (Morquio-A syndrome)","volume":"11","author":"Kampmann","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.05.015_bib63","doi-asserted-by":"crossref","first-page":"31237","DOI":"10.1074\/jbc.M801586200","article-title":"Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution","volume":"283","author":"Mochizuki","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.05.015_bib64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/bmc.760","article-title":"Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo-ionspray ionization tandem mass spectrometry","volume":"21","author":"Oguma","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.omtm.2020.05.015_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2007.05.016","article-title":"Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry","volume":"368","author":"Oguma","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.omtm.2020.05.015_bib66","first-page":"15","article-title":"Chondroitin 6-sulfate as a novel biomarker for mucopolysaccharidosis IVA and VII","volume":"16","author":"Shimada","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.omtm.2020.05.015_bib67","first-page":"1","article-title":"Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB","volume":"21","author":"Shimada","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.omtm.2020.05.015_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.05.015_bib69","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/ddg119","article-title":"Production of MPS VII mouse (Gustm(hE540A x mE536A)Sly) doubly tolerant to human and mouse \u03b2-glucuronidase","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:30:05Z","timestamp":1762421405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":69,"alternative-id":["S2329050120301029"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.015","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}